1. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma
   Xiaoran Li et al, 2021, BMC Cancer CrossRef
2. Vaginal Microbiome and Its Role in HPV Induced Cervical Carcinogenesis
   Erik Kudela et al, 2023, Microbiome in 3P Medicine Strategies CrossRef
3. PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer
   Frank Köster et al, 2020, Oncology Letters CrossRef
4. Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer
   Nima Hemmat et al, 2020, Molecular Biology Reports CrossRef
5. Development of machine learning models integrating PET/CT radiomic and immunohistochemical pathomic features for treatment strategy choice of cervical cancer with negative pelvic lymph node by mediating COX-2 expression
   Zhe Zhang et al, 2022, Frontiers in Physiology CrossRef
6. Interaction of cervical microbiome with epigenome of epithelial cells: Significance of inflammation to primary healthcare
   Veronika Holubekova et al, 2022, Biomolecular Concepts CrossRef
7. Ligand fishing as a tool to screen natural products with anticancer potential
   Luiz Antonio Miranda de Souza Duarte‐Filho et al, 2023, Journal of Separation Science CrossRef
8. Resveratrol promotes regression of renal carcinoma cells via a renin-angiotensin system suppression-dependent mechanism
   Jianchang Li et al, 2017, Oncology Letters CrossRef
9. Clinical application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics-based machine learning analyses in the field of oncology
   Masatoyo Nakajo et al, 2024, Japanese Journal of Radiology CrossRef
10. Investigational drugs for the treatment of cervical cancer
    Fabio Barra et al, 2017, Expert Opinion on Investigational Drugs CrossRef
11. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
    Maximilian Fleischmann et al, 2021, Cancers CrossRef